6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-1-one, 98%, 10g

5-Bromo-2-thiophenecarboxylic acid, 97.0%, 5g

Methyl 3-amino-2-methoxyisonicotinate, 95.0%, 250mg

2-(Cyclopentylidenemethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

SULFASALAZINE, 97%, 100g

Methyl 3-amino-5-nitrobenzo[b]thiophene-2-carboxylate, 95.0%, 10g

4-Cyclobutoxy-3,5-difluorobenzoic acid, 1g

Pyridazin-4-ylmethanamine hydrochloride, 95.0%, 250mg

2-(2,3,4-Trichlorophenyl)quinoline-4-carboxylic acid, 97%, 100mg

(11R,12R)-9,10-Dihydro-9,10-ethanoanthracene-11,12-diamine>98.0%(HPLC)(T)1g

4-Chloro-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 5g

(S)-4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid compound with benzenesulfonic acid (1:1), 98%, 10mg

3-tert-Butyl-L-alanine, 97.0%, 250mg